VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ORGN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ORGNOrigin Materials, Inc.
$0.95$5M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. ORGN
  4. Financial Ratios

Origin Materials, Inc. (ORGN) Financial Ratios

Latest Ratios: P/E Ratio -0.0x · EV/EBITDA N/A · ROE -112.8%. (2019–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

ORGN Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Market Cap$5M$31M$183M$119M$655M$685M$665M—
Enterprise Value$10631$26M$137M$54M$556M$646M$673M—
P/E Ratio →-0.02——5.028.3416.27——
P/S Ratio0.281.665.864.14————
P/B Ratio0.040.300.540.281.742.265405.27—
P/FCF————————
P/OCF————————

P/E links to full P/E history page with 30-year chart

ORGN EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
EV / Revenue—1.384.371.86————
EV / EBITDA——————57.71—
EV / EBIT———2.357.0814.37——
EV / FCF————————

ORGN Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Gross Margin2.9%2.9%1.3%18.1%————
Operating Margin-335.4%-335.4%-271.3%-190.5%————
Net Profit Margin-1319.6%-1319.6%-267.6%82.6%————

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
ROE-112.8%-112.8%-22.0%6.0%23.1%27.7%-210.0%-1.7%
ROA-93.2%-93.2%-19.9%5.0%15.6%15.1%-63.6%-1.0%
ROIC-24.4%-24.4%-19.6%-13.0%-10.8%-14.9%37.4%—
ROCE-25.7%-25.7%-20.8%-11.9%-7.9%-9.9%26.3%24.5%

ORGN Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Debt / Equity0.270.270.030.020.020.0275.830.38
Debt / EBITDA——————0.800.94
Net Debt / Equity—-0.05-0.14-0.16-0.26-0.1365.190.28
Net Debt / EBITDA——————0.690.68
Debt / FCF————————
Interest Coverage-2024.02-2024.02-222.80174.37—15.83-32.79—

Net cash position: cash ($33M) exceeds total debt ($28M)

ORGN Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Current Ratio2.832.8311.0914.5516.73107.760.261.92
Quick Ratio2.812.8111.0214.4816.73107.760.261.92
Cash Ratio1.871.878.2012.3016.32106.070.171.18
Asset Turnover—0.120.080.06————
Inventory Turnover26.8726.8735.6425.87————
Days Sales Outstanding—292.24253.26248.07————

ORGN Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Dividend Yield————————
Payout Ratio————————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Earnings Yield———19.9%12.0%6.1%——
FCF Yield————————
Buyback Yield0.0%0.0%0.0%0.0%0.0%0.0%0.0%—
Total Shareholder Yield0.0%0.0%0.0%0.0%0.0%0.0%0.0%—
Shares Outstanding—$5M$5M$5M$5M$4M$2M$1M

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Capital exhaustion and dilution

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Market Pricing Reflects Distressed Outlook

According to current market data, ORGN trades at a P/S multiple of 0.25, which, when compared to historical levels and specialty chemical peers, suggests that investors have largely abandoned growth expectations in favor of pricing the company based on its remaining tangible asset base.

The depressed P/S ratio indicates that the market is heavily discounting the company's future revenue potential, likely due to the persistent failure to scale commercial operations. This valuation level implies that the market views the current business model as a distressed asset rather than a growth-stage technology firm.

Capital Compounding Remains Deeply Negative

As reported in financial statements, the company's ROIC has remained consistently negative, reaching -13.5% in 2026Q1, which highlights a structural inability to generate returns on invested capital that exceed the cost of funding its capital-intensive thermochemical conversion infrastructure.

The persistent decay in ROIC suggests that the capital deployed into the Sarnia facility and other projects has failed to produce the expected economic value. Investors should monitor whether management can pivot to a less capital-intensive licensing model to reverse this trend, as current returns are fundamentally unsustainable.

Working Capital Cycles Indicate Friction

Based on quarterly data, the cash conversion cycle has ballooned to 1,980 days in 2026Q1, a significant deterioration from historical norms that reflects severe operational inefficiencies and a lack of meaningful product throughput compared to the company's peers in the industrial materials sector.

This extreme CCC figure suggests that the company is struggling to manage its inventory and receivables effectively, likely due to the lack of a stable, recurring customer base. The inability to turn over assets efficiently implies that the current operational setup is not yet optimized for commercial-scale production.

Liquidity Runway Narrows Under Pressure

As indicated by the company's latest balance sheet, the current ratio has declined to 2.66 in 2026Q1, which, while appearing superficially healthy, masks a rapid depletion of cash reserves that leaves the firm vulnerable to further operational setbacks or unexpected capital requirements.

While the current ratio remains above parity, the absolute cash balance is insufficient to support the company's high fixed-cost structure for an extended period. This liquidity position warrants close monitoring, as the firm may be forced to seek dilutive financing if it cannot achieve self-sustaining cash flow soon.

Misapplied Focus on P/S Multiples

Investors frequently misapply the Price-to-Sales ratio to ORGN, which obscures the reality that the company's current revenue is largely transactional and non-recurring, making it a poor proxy for the long-term value of its proprietary thermochemical conversion intellectual property.

Instead of relying on P/S, analysts should focus on the 'burn-to-milestone' ratio, which measures the cash required to reach the next technical or commercial inflection point. Using P/S in this context ignores the high probability of equity dilution, which is the primary risk factor for shareholders in this specific business model.

Download Financial Ratios Data

Includes 30+ ratios · 7 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

ORGN — Frequently Asked Questions

Quick answers to the most common questions about buying ORGN stock.

What is Origin Materials, Inc.'s P/E ratio?

Origin Materials, Inc.'s current P/E ratio is -0.0x. The historical average is 9.9x.

What is Origin Materials, Inc.'s ROE?

Origin Materials, Inc.'s return on equity (ROE) is -112.8%. The historical average is -41.4%.

Is ORGN stock overvalued?

Based on historical data, Origin Materials, Inc. is trading at a P/E of -0.0x. Compare with industry peers and growth rates for a complete picture.

What are Origin Materials, Inc.'s profit margins?

Origin Materials, Inc. has 2.9% gross margin and -335.4% operating margin.